Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Spector

Showing results (921-930 of 939) with videos related to

Pageof 94
Sort By:
The Journal of Infectious Diseases|November 24, 2019
Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in ChildrenElizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
The Journal of Infectious Diseases|May 1, 1997
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study GroupR J Whitley, G Cloud, W Gruber, et al.
The Journal of Infectious Diseases|March 7, 2018
Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in ChildrenElizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
Archives of Internal Medicine|May 20, 1998
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USAR J Whitley, M A Jacobson, D N Friedberg, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Breast adipose tissue-derived extracellular vesicles from women with obesity stimulate mitochondrial-induced dysregulated tumor cell metabolismShuchen Liu, Alberto Benito-Martin, Fanny A Pelissier Vatter, et al.
The New England Journal of Medicine|December 22, 1999
Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 TeamS E Starr, C V Fletcher, S A Spector, et al.
The Lancet. HIV|December 7, 2023
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept studyDeborah Persaud, Yvonne Bryson, Bryan S Nelson, et al.
EMBO Reports|November 6, 2023
Breast adipose tissue-derived extracellular vesicles from obese women alter tumor cell metabolismShuchen Liu, Alberto Benito-Martin, Fanny A Pelissier Vatter, et al.
AIDS (London, England)|May 30, 2024
Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapyThor A Wagner, Camlin Tierney, Sharon Huang, et al.
The Journal of Infectious Diseases|November 9, 2000
Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials GroupL M Frenkel, E V Capparelli, W M Dankner, et al.
Pageof 94

Showing results (921-930 of 939) with videos related to

Sort By:
Pageof 94
The Journal of Infectious Diseases|November 24, 2019
Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in ChildrenElizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
The Journal of Infectious Diseases|May 1, 1997
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study GroupR J Whitley, G Cloud, W Gruber, et al.
The Journal of Infectious Diseases|March 7, 2018
Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in ChildrenElizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
Archives of Internal Medicine|May 20, 1998
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USAR J Whitley, M A Jacobson, D N Friedberg, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Breast adipose tissue-derived extracellular vesicles from women with obesity stimulate mitochondrial-induced dysregulated tumor cell metabolismShuchen Liu, Alberto Benito-Martin, Fanny A Pelissier Vatter, et al.
The New England Journal of Medicine|December 22, 1999
Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 TeamS E Starr, C V Fletcher, S A Spector, et al.
The Lancet. HIV|December 7, 2023
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept studyDeborah Persaud, Yvonne Bryson, Bryan S Nelson, et al.
EMBO Reports|November 6, 2023
Breast adipose tissue-derived extracellular vesicles from obese women alter tumor cell metabolismShuchen Liu, Alberto Benito-Martin, Fanny A Pelissier Vatter, et al.
AIDS (London, England)|May 30, 2024
Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapyThor A Wagner, Camlin Tierney, Sharon Huang, et al.
The Journal of Infectious Diseases|November 9, 2000
Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials GroupL M Frenkel, E V Capparelli, W M Dankner, et al.
Pageof 94